Clinical Trial Update: Assessment of Residual Allergenicity of Tree (Birch, Hazel, and Alder) Pollen Allergoid Using Skin Prick Testing [Phase 1]

View source ↗

Summary

Phase 1 trial assessing residual allergenicity of a tree pollen allergoid (birch, hazel, alder) using skin prick testing; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type Hypersensitivity

Drugs mentioned

• Tree Pollen Allergoid (birch, hazel, alder) (allergoid)

Snippet

Sponsor: Allergy Therapeutics | Conditions: Type I Hypersensitivity | Phase 1 | Status: COMPLETED